|
WO2009060281A2
|
|
Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
|
|
KR20100068422A
|
|
Immune stimulatory oligonucleotide analogs containing modified sugar moieties
|
|
CN101821392A
|
|
RNA sequence motifs in the context of defined inter-nucleotide linkages inducing specific immune modulatory profiles
|
|
WO2008142513A2
|
|
Phosphate-modified oligonucleotide analogs with immunostimulatory activity
|
|
AU2008200016A1
|
|
Combination motif immune stimulatory oligonucleotides with improved activity
|
|
BRPI0718182A2
|
|
Oligorribonucleotids and their uses.
|
|
KR20090058581A
|
|
Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity
|
|
US2008045473A1
|
|
Compositions and methods for oligonucleotide formulations
|
|
BRPI0622298A2
|
|
oligoribonucleotide to stimulate production of a proinflammatory cytokine, use thereof and composition containing such oligoribonucleotide
|
|
CN101331229A
|
|
Immunostimulatory oligoribonucleotides
|
|
AU2006294528A1
|
|
Modulation of TLR-mediated immune responses using adaptor oligonucleotides
|
|
EA013468B1
|
|
Immunostimulatory single-stranded ribonucleic acid with phosphodiester backbone
|
|
JP2007151536A
|
|
C-class oligonucleotide analog with enhanced immunostimulatory potency
|
|
CA2567789A1
|
|
Abasic oligonucleotide as carrier platform for antigen and immunostimulatory agonist and antagonist
|
|
WO2005097993A2
|
|
Immunostimulatory viral rna oligonucleotides
|
|
NZ546275A
|
|
C-class oligonucleotides analogs with enhanced immunostimulatory potency
|
|
AU2004275876A1
|
|
Nucleic acid-lipophilic conjugates
|
|
AU2004203808A1
|
|
G-Motif Oligonucleotides and Uses Thereof
|
|
CN1809357A
|
|
Small molecule Toll-like receptor (TLR) antagonists
|
|
EP1635846A2
|
|
Small molecule toll-like receptor (tlr) antagonists
|
